Gasdermin D as a Promising Biomarker for Lung Cancer Detection | Potential for Early Diagnosis and Improved Patient Outcomes

In this episode of SciBud, join host Maple as we unpack a groundbreaking study that shines a light on the fight against lung cancer through the lens of bioimaging. Discover how the protein Gasdermin D (GSDMD) could revolutionize early detection and prognosis by serving as a potential biomarker for this deadly disease, which accounts for nearly 18% of cancer-related deaths worldwide. With research highlighting GSDMD levels significantly higher in lung cancer patients compared to others, and impressive diagnostic sensitivity rates, this episode reveals how combining GSDMD with traditional markers could improve detection accuracy. However, we also explore critical perspectives on data transparency and the need for further validation in this promising yet nascent field of study. Tune in to learn how innovation in cancer diagnostics could lead to better outcomes and to foster your own curiosity about the science unfolding around us! Link to episode page with article citation: www.scibud.media/podcast/season/2025/episode/147